QC
MIST icon

Quadrature Capital’s Milestone Pharmaceuticals MIST Stock Holding History

Quadrature Capital’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$177K Buy
+149,105
New +$261K ﹤0.01% 1144
2025
Q4 		– Sell
-223,470
Closed -$448K – 1514
2025
Q3 		$448K Buy
+223,470
New +$393K 0.01% 557

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Quadrature Capital's MIST Position: Q1 2026 in Review

Quadrature Capital opened a new position in Milestone Pharmaceuticals (MIST) in Q1 2026: 149,105 shares worth $177K. The stake represents ﹤0.01% of the portfolio and ranks #1144 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in MIST as recently as Q3 2025.

Quadrature Capital first reported a position in MIST in Q3 2025 and has held it in 2 quarters since. The position peaked at $448K in Q3 2025. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Quadrature Capital held 149,105 shares of Milestone Pharmaceuticals worth $177K as of Q1 2026.
  • Milestone Pharmaceuticals was a new Quadrature Capital position in Q1 2026.
  • Milestone Pharmaceuticals made up ﹤0.01% of Quadrature Capital's portfolio in Q1 2026, its #1144 holding.
  • Quadrature Capital first reported a position in Milestone Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • Quadrature Capital's Milestone Pharmaceuticals position peaked at $448K in Q3 2025.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.